Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerda Mitteregger

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Molecular Immunology|June 20, 2007
Single chain Fv antibodies directed against the 37 kDa/67 kDa laminin receptor as therapeutic tools in prion diseasesChantal Zuber, Stefan Knackmuss, Clémence Rey, et al.
The Journal of General Virology|July 18, 2008
Delivery of single-chain antibodies (scFvs) directed against the 37/67 kDa laminin receptor into mice via recombinant adeno-associated viral vectors for prion disease gene therapyChantal Zuber, Gerda Mitteregger, Natascha Schuhmann, et al.
Plos One|December 9, 2017
Substitutions of PrP N-terminal histidine residues modulate scrapie disease pathogenesis and incubation time in transgenic miceSabina Eigenbrod, Petra Frick, Uwe Bertsch, et al.
Acta Neuropathologica|April 23, 2013
Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson's diseaseJens Wagner, Sergey Ryazanov, Andrei Leonov, et al.
Nature Communications|August 8, 2025
Early Locus Coeruleus noradrenergic axon loss drives olfactory dysfunction in Alzheimer's diseaseCarolin Meyer, Theresa Niedermeier, Paul L C Feyen, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Molecular Immunology|June 20, 2007
Single chain Fv antibodies directed against the 37 kDa/67 kDa laminin receptor as therapeutic tools in prion diseasesChantal Zuber, Stefan Knackmuss, Clémence Rey, et al.
The Journal of General Virology|July 18, 2008
Delivery of single-chain antibodies (scFvs) directed against the 37/67 kDa laminin receptor into mice via recombinant adeno-associated viral vectors for prion disease gene therapyChantal Zuber, Gerda Mitteregger, Natascha Schuhmann, et al.
Plos One|December 9, 2017
Substitutions of PrP N-terminal histidine residues modulate scrapie disease pathogenesis and incubation time in transgenic miceSabina Eigenbrod, Petra Frick, Uwe Bertsch, et al.
Acta Neuropathologica|April 23, 2013
Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson's diseaseJens Wagner, Sergey Ryazanov, Andrei Leonov, et al.
Nature Communications|August 8, 2025
Early Locus Coeruleus noradrenergic axon loss drives olfactory dysfunction in Alzheimer's diseaseCarolin Meyer, Theresa Niedermeier, Paul L C Feyen, et al.
Pageof 4